Back to resultsBiPAP for Cardiomyopathy With Central Sleep Apnea
Primary Purpose
Dilated Cardiomyopathy
Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
bilevel positive airway pressure
bilevel positive airway pressure (Device)
Sponsored by
About this trial
This is an interventional treatment trial for Dilated Cardiomyopathy
Eligibility Criteria
Inclusion Criteria: Idiopathic dilated cardiomyopathy Exclusion Criteria: a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease
Sites / Locations
- Nagoya University of Health Sciences
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00282789
Brief Title
BiPAP for Cardiomyopathy With Central Sleep Apnea
Study Type
Interventional
2. Study Status
Record Verification Date
June 2000
Overall Recruitment Status
Completed
Study Start Date
June 2000 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Nagoya University
4. Oversight
5. Study Description
Brief Summary
We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dilated Cardiomyopathy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
bilevel positive airway pressure
Intervention Type
Device
Intervention Name(s)
bilevel positive airway pressure (Device)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Idiopathic dilated cardiomyopathy
Exclusion Criteria:
a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mitsuhiro Yokota, MD,PhD
Organizational Affiliation
Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan
Official's Role
Study Chair
Facility Information:
Facility Name
Nagoya University of Health Sciences
City
Nagoya
ZIP/Postal Code
461-8673
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
BiPAP for Cardiomyopathy With Central Sleep Apnea
We'll reach out to this number within 24 hrs